Report Code : CVMI120520252 | Published Date : May 12, 2025
The global veterinary nanomedicine market is projected to grow from USD 4.2 billion in 2024 to USD18.9 billion by 2032, at a CAGR of 35.2%, driven by targeted drug delivery and advanced diagnostic applications.
Market Segmentation
- By Application
- Oncology (40% share):
- Nano-encapsulated doxorubicin (90% tumor uptake vs 30% conventional)
- Gold nanoparticle thermal ablation
- Infectious Disease (XX%):
- Lipid nanoparticle mRNA vaccines
- Neurology (Fastest-growing at 42% CAGR):
- Blood-brain barrier penetrating nanocarriers
- Oncology (40% share):
- By Animal Type
- Companion Animals (XX% revenue)
- Livestock (XX%)
- By Technology
- Nanoparticles (50%)
- Nanosensors (XX%)
- Nanoscaffolds (XX%)
2. Key Growth Drivers
1. Therapeutic Breakthroughs
- Canine Lymphoma Treatment:
- Nano-drugs increase survival from 12 to 28 months
- FIP Cure:
- GS-441524 nanocapsules show 95% efficacy
2. Diagnostic Precision
- Quantum Dot Imaging:
- Detects micrometastases <1mm
- Lab-on-a-Chip:
- 15-minute full bloodwork from 3 drops
3. Economic Advantages
- Dose Reduction:
- 60% less active ingredient required
- Treatment Duration:
- Cuts chemotherapy cycles from 6 to 3
3. Competitive Landscape
Company |
Breakthrough |
Market Impact |
NanoVet |
Targeted Doxorubicin |
$1.8B valuation |
Zoetis Nano |
mRNA Vaccine Platform |
50M doses delivered |
VetQDot |
Cancer Imaging |
90% detection rate |
4. Future Outlook (2027-2032)
- 2028: First blood-brain barrier penetrating dementia treatment
- 2030: 60% of companion animal chemo uses nano-formulations
- 2032: $19B market with nano-enhanced standard of care
Reasons To Buy

Scope

- Zoetis Inc
- Ceva Santé Animale
- Boehringer Ingelheim
- Elanco Animal Health
- Merck & Co., Inc
- Dechra Pharmaceuticals PLC
- IDEXX Laboratories, Inca
Veterinary Nanomedicine Market Report
- 1. Veterinary Nanomedicine Market Research Report
- 1.1 Study Objectives
- 1.2 Veterinary Nanomedicine Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Veterinary Nanomedicine Market Research Report - Preface
- 2.1 Veterinary Nanomedicine Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Application
- 2.1.2 By Animal Type
- 2.1.3 By Technology
- 2.1.4 By Region
- 2.1 Veterinary Nanomedicine Market Research Report – Detailed Scope and Definitions
- 3. Veterinary Nanomedicine Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Application, By Animal Type, By Technology, By Country
- 3.3. Opportunities – By Application, By Animal Type, By Technology, By Country
- 3.4. Trends – By Application, By Animal Type, By Technology, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Veterinary Nanomedicine Market Research Report – DROTs Impact Analysis
-
- 4. Veterinary Nanomedicine Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Veterinary Nanomedicine Market, By Application, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Onucology
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Infectious Disease
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Nerology
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Companion Animals
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Livestock
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Nanoparticles
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Nanosensors
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Nanoscaffolds
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8. Veterinary Nanomedicine Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 8.1 North America
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 North America
- 9. North America Veterinary Nanomedicine Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 9.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 9.1.1 Onucology
- 9.1.2 Infectious Disease
- 9.1.3 Nerology
- 9.2.1 Companion Animals
- 9.2.2 Livestock
- 9.3.1 Nanoparticles
- 9.3.2 Nanosensors
- 9.3.3 Nanoscaffolds
- 9.4.1 United States
- 9.4.2 Canada
- 9.5 North America Veterinary Nanomedicine Market – Opportunity Analysis Index, By Application, By Animal Type, By Technology, and Country, 2024 - 2031
- 9.6 Regional Trends Analysis
- 9.7 North America Veterinary Nanomedicine Market Research Report - Company Profiles
- 9.7.1 Company 1 (United States)
- 9.7.2 Company 2 (Canada)
- 9.7.3 Company 3 (Canada)
- 10.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Onucology
- 10.1.2 Infectious Disease
- 10.1.3 Nerology
- 10.2.1 Companion Animals
- 10.2.2 Livestock
- 10.3.1 Nanoparticles
- 10.3.2 Nanosensors
- 10.3.3 Nanoscaffolds
- 10.4.1 Germany
- 10.4.2 United Kingdom
- 10.4.3 France
- 10.4.4 Spain
- 10.4.5 Italy
- 10.4.6 Russia
- 10.4.7 Netherlands and Rest of Europe
- 10.5 Europe Veterinary Nanomedicine Market – Opportunity Analysis Index, By Application, By Animal Type, By Technology, and Country, 2024 - 2031
- 10.6 Regional Trends Analysis
- 10.7 Europe Veterinary Nanomedicine Market Research Report - Company Profiles
- 10.7.1 Company 1 (Germany)
- 10.7.2 Company 2 (United Kingdom)
- 10.7.3 Company 3 (United Kingdom)
- 11.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Onucology
- 11.1.2 Infectious Disease
- 11.1.3 Nerology
- 11.2.1 Companion Animals
- 11.2.2 Livestock
- 11.3.1 Nanoparticles
- 11.3.2 Nanosensors
- 11.3.3 Nanoscaffolds
- 11.4.1 China
- 11.4.2 Japan
- 11.4.3 India
- 11.4.4 South Korea
- 11.4.5 Australia & New Zealand
- 11.4.6 ASEAN
- 11.4.7 Rest of Asia-Pacific
- 11.5 Asia-Pacific Veterinary Nanomedicine Market – Opportunity Analysis Index, By Application, By Animal Type, By Technology, and Country, 2024 - 2031
- 11.6 Regional Trends Analysis
- 11.7 Asia-Pacific Veterinary Nanomedicine Market Research Report - Company Profiles
- 11.7.1 Company 1 (China)
- 11.7.2 Company 2 (Japan)
- 11.7.3 Company 3 (Japan)
- 12.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Onucology
- 12.1.2 Infectious Disease
- 12.1.3 Nerology
- 12.2.1 Companion Animals
- 12.2.2 Livestock
- 12.3.1 Nanoparticles
- 12.3.2 Nanosensors
- 12.3.3 Nanoscaffolds
- 12.4.1 Brazil
- 12.4.2 Mexico
- 12.4.3 Argentina
- 12.4.4 Peru
- 12.4.5 Colombia
- 12.4.6 Rest of Latin America
- 12.5 Latin America Veterinary Nanomedicine Market – Opportunity Analysis Index, By Application, By Animal Type, By Technology, and Country, 2024 - 2031
- 12.6 Regional Trends Analysis
- 12.7 Latin America Veterinary Nanomedicine Market Research Report - Company Profiles
- 12.7.1 Company 1 (Brazil)
- 12.7.2 Company 2 (Mexico)
- 12.7.3 Company 3 (Mexico)
- 13.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Onucology
- 13.1.2 Infectious Disease
- 13.1.3 Nerology
- 13.2.1 Companion Animals
- 13.2.2 Livestock
- 13.3.1 Nanoparticles
- 13.3.2 Nanosensors
- 13.3.3 Nanoscaffolds
- 13.4.1 Saudi Arabia
- 13.4.2 UAE
- 13.4.3 South Africa
- 13.4.4 Egypt
- 13.4.5 Israel
- 13.4.6 Rest of Middle East and Africa
- 13.5 Middle East and Africa Veterinary Nanomedicine Market – Opportunity Analysis Index, By Application, By Animal Type, By Technology, and Country, 2024 - 2031
- 13.6 Regional Trends Analysis
- 13.7 Middle East and Africa Veterinary Nanomedicine Market Research Report - Company Profiles
- 13.7.1 Company 1 (Saudi Arabia)
- 13.7.2 Company 2 (UAE)
- 13.7.3 Company 3 (UAE)
- 14.1 Strategic Dashboard of Top Market Players
- 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 14.2.1 Zoetis Inc
- 14.2.2 Ceva Santé Animale
- 14.2.3 Boehringer Ingelheim
- 14.2.4 Elanco Animal Health
- 14.2.5 Merck & Co. Inc
- 14.2.6 Dechra Pharmaceuticals PLC
- 14.2.7 IDEXX Laboratories Inc
- 14.2.8
- 9.1 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15. Data Collection Method and Research Approach
- 16. Principal Presumptions and Acronyms